Literature DB >> 17991349

Chronic conditions in adult survivors of childhood cancer.

Robert J Wells.   

Abstract

Entities:  

Year:  2007        PMID： 17991349     DOI： 10.1007/s11912-007-0060-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  5 in total

Review 1.  Late effects of childhood cancer therapy.

Authors:  Debra L Friedman; Anna T Meadows
Journal:  Pediatr Clin North Am       Date:  2002-10       Impact factor: 3.278

Review 2.  Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors.

Authors:  Kevin C Oeffinger; Melissa M Hudson
Journal:  CA Cancer J Clin       Date:  2004 Jul-Aug       Impact factor: 508.702

3.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Authors:  James B Nachman; Richard Sposto; Philip Herzog; Gerald S Gilchrist; Suzanne L Wolden; John Thomson; Marshall E Kadin; Paul Pattengale; P Charlton Davis; Raymond J Hutchinson; Keith White
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

4.  High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

Authors:  Smita Bhatia; Yutaka Yasui; Leslie L Robison; Jillian M Birch; Monica K Bogue; Lisa Diller; Cyndi DeLaat; Franca Fossati-Bellani; Elaine Morgan; Odile Oberlin; Gregory Reaman; Frederick B Ruymann; Jean Tersak; Anna T Meadows
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

5.  Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

Authors:  A C Mertens; Y Yasui; J P Neglia; J D Potter; M E Nesbit; K Ruccione; W A Smithson; L L Robison
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 50.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.